PATEL NAIMISH (Chief Medical Officer) purchased 1.51K shares of CRISPR THERAPEUTICS AG on the open market
Open‑market purchase worth $49.7K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/27/2026ACC: 0001193125-26-024955
Officer· Chief Medical Officer
Since Apr 2025
+1.51K
Net shares
Net buyer
$49.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.51K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+1.51K
Price / share
$32.96
Trade value
$49.70K
% of position
New position
4/3/2025
0.00→1.51K
Total
Net shares
+1.51K
Net value
$49.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 4/3/2025 | P · Purchase | +1.51K | $32.96 | $49.70K | New position | 0.00 | 1.51K |
| Total | +1.51K | $49.70K | ||||||
Derivative Transactions0
No derivative transactions reported